PAVmed Inc.
PAVM
NASDAQ·Healthcare·Medical - Devices·Mkt cap $33.7M
$5.28
▲ +3.73%
P/E
—
Mkt Cap
$33.7M
52-Wk Range
$3.85–$28.44
52-Week Range
$3.85 - $28.44
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 59.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Stable outlook
Value
Deep value opportunity - significant discount to sector peers
Momentum
Stable
-3.1% over 3m
Quality
Loss-making
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying PAVM right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 12, 2026
AUG 14, 2026
Reported EPS of -$0.87 vs -$0.47 consensus (-85.1% surprise). Revenue of $33.0K vs $48.0K expected (-31.3%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-85.1%
Revenue trend · last 2Q
—
—
Q1 26
Q2 26
$22.0M
$33.0M
Margins · last 2Q
Profit
-16603.0%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Ascendiant Capital · Aug 27, 2026
vs Industry
How PAVM stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.